Press Releases-2010
| October 2010 | |
|
Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations Size: Kb |
|
|
Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar® Size: Kb |
|
| August 2010 | |
|
Lupin appoints Paul McGarty as President for Lupin Pharmaceuticals Inc. Size: Kb |
|
| July 2010 | |
|
Lupin Net Profit up by 40 % in Q1, FY 2010-11 Consistent Growth, Strong Profits Size: Kb |
|
|
Lupin receives FDA approval for Famotidine for Oral Suspension Size: Kb |
|
| June 2010 | |
|
Lupin receives FDA approval for Lamotrigine tablets Size: Kb |
|
| May 2010 | |
|
Lupin FY 2009-10 Consolidated Net Profits up 36% to Rs 6816 mn Size: Kb |
|
| April 2010 | |
|
Lupin receives FDA approval for Imipramine Pamoate Capsules Size: Kb |
|
| March 2010 | |
|
Lupin launches Hyalgan® in India Marks foray into the Orthopaedics segment Size: Kb |
|
|
Lupin receives FDA tentative approval for Eszopiclone tablets Size: Kb |
|
| Febuary 2010 | |
|
Lupin receives US FDA approval for Amlodipine / Benazepril capsules Size: Kb |
|